Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma

Standard treatment for locally advanced rectal adenocarcinoma (LARC) includes a combination of chemotherapy with pyrimidine analogues, such as capecitabine, and radiation therapy, followed by surgery. Currently no clinically useful genomic predictors of benefit from neoadjuvant chemoradiotherapy (nC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrando, Lorenzo, Cirmena, Gabriella, Garuti, Anna, Scabini, Stefano, Grillo, Federica, Mastracci, Luca, Isnaldi, Edoardo, Marrone, Ciro, Gonella, Roberta, Murialdo, Roberto, Fiocca, Roberto, Romairone, Emanuele, Ballestrero, Alberto, Zoppoli, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001901/
https://www.ncbi.nlm.nih.gov/pubmed/32023246
http://dx.doi.org/10.1371/journal.pone.0226595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001901/
https://www.ncbi.nlm.nih.gov/pubmed/32023246
http://dx.doi.org/10.1371/journal.pone.0226595

Ejemplares similares